Cabaletta Bio (NASDAQ:CABA) Earns Buy Rating from Guggenheim
Cabaletta Bio (NASDAQ:CABA – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at Guggenheim in a research note issued on Tuesday,Benzinga reports. They presently have a $23.00 price objective on the stock. A number of other analysts have also recently weighed in on the stock. Wells Fargo & Company cut shares […]
Cabaletta Bio (NASDAQ:CABA – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at Guggenheim in a research note issued on Tuesday,Benzinga reports. They presently have a $23.00 price objective on the stock. A number of other analysts have also recently weighed in on the stock. Wells Fargo & Company cut shares […]
